Sabon Maganin COVID-19 Na Baki Yana Nuna Faruwa 100%.

Sakin Kyauta | eTurboNews | eTN
Written by Linda Hohnholz

Kamfanin Golden Biotechnology Corp. wani kamfani ne na biopharmaceutical na Taiwan, ya sanar da cewa gwajin sa na mataki na 2 COVID-19 na sabon maganin maganin baka na Antroquinonol (HOCENA®) ya sami sakamakon farfadowar kashi 100% na ma'aunin sakamakon sa na farko a asibiti mai laushi, matsakaici gami da marasa lafiya na ICU.

Dangane da shirin, GoldenBiotech zai gabatar da rahoton bincike na gwaji na asibiti na ƙarshe da takaddun R&D masu alaƙa ga FDA ta Amurka don neman izinin amfani da gaggawa (EUA) don Antroquinonol (HOCENA®).          

Wannan gwajin gwaji ne na Mataki na 2 bazuwar, makafi biyu, nazari mai sarrafa wuribo don kimanta aminci da ingancin Antroquinonol a cikin marasa lafiya na asibiti tare da ciwon huhu mai laushi zuwa matsakaici saboda COVID-19 (cutar Coronavirus SARS-CoV-2). A zahiri, gwajin ya kuma haɗa da majinyata masu tsanani na ICU waɗanda ke buƙatar tallafin iskar oxygen. Bayan kammala duk kimantawa na nunawa da saduwa da ka'idojin cancanta, marasa lafiya za su sami 100mg na Antroquinonol ko placebo sau biyu a rana don kwanaki 14 a hade tare da Tsarin Kulawa (SoC) ta kowace manufofin SoC na gida. Gwajin ya kammala daukar ma'aikata ga marasa lafiya 124 a cikin Amurka, Peru da Argentina inda sabon barkewar cutar ta yadu tare da bambance-bambancen SARS-CoV-2 da ke yaduwa.

Bayanan gwaji na asibiti sun bayyana:

1. Ma'auni na Farko na Farko: rabon farfadowa [Tsarin lokaci: kwanaki 14]Yawancin marasa lafiya waɗanda ke raye kuma ba su da gazawar numfashi (misali, babu buƙatar iskar inzali, iska mara ƙarfi, iskar oxygen mai ƙarfi, ko ECMO) akan Ranar 14.Sakamako: A cikin rukunin Antroquinonol, rabon dawowa shine 97.9% a ranar 14 ziyara. Bugu da ƙari kuma, ba a sami mutuwa ko gazawar numfashi ba a cikin rukunin Antroquinonol a ziyarar ranar 28 tare da rabon farfadowa na 100%.

2. Ma'auni na Sakandare na biyu: (a) Tsawon lokacin ICU Tsaya: Sakamako: Tsakanin lokacin zaman ICU a cikin rukunin Antroquinonol ya kasance kwanaki 9.5 ya fi guntu a cikin rukunin placebo. (b) Tsawon lokacin asibiti [Tsarin lokaci: kwanaki 28]: lokacin fitarwa na haƙuri.Sakamako: Tsakanin tsaka-tsakin lokacin asibiti shine kwanaki 4 a cikin rukunin Antroquinonol. Makin canji na asibiti kamar yadda aka auna ta "WHO COVID-2 Clinical Ingantattun Siffar Sikeli".Sakamakon: Matsakaicin lokacin da za a ci 28 a cikin "WHO COVID-19 Cibiyar Inganta Lafiya ta Farko" ya kasance kwanaki 0 a cikin rukunin antroquinonol.(d) Lokaci zuwa izinin virological [Tsarin lokaci: kwanaki 19]: an auna azaman kwanakin karatu daga farkon jiyya zuwa gwajin SARS-CoV-29 PCR mara kyau.Sakamakon: Tsakanin lokacin tsaka-tsaki zuwa izinin virological shine kwanaki 28 a cikin rukunin Antroquinonol.

A cikin ƙididdigar aminci, bayanan sun nuna cewa Antroquinonol ya nuna kyakkyawan haƙuri da sakamakon aminci.

<

Game da marubucin

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...